Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1


Por: Loza-Huerta, Arlet, Milo, Edgar, Picones, Arturo, Hernandez-Cruz, Arturo, Luis, Enoch

Publicada: 1 dic 2021 Ahead of Print: 1 jul 2021
Resumen:
Background Ion channels have been proposed as therapeutic targets for different types of malignancies. One of the most studied ion channels in cancer is the voltage-gated potassium channel ether-a-go-go 1 or Kv10.1. Various studies have shown that Kv10.1 expression induces the proliferation of several cancer cell lines and in vivo tumor models, while blocking or silencing inhibits proliferation. Kv10.1 is a promising target for drug discovery modulators that could be used in cancer treatment. This work aimed to screen for new Kv10.1 channel modulators using a thallium influx-based assay. Methods Pharmacological effects of small molecules on Kv10.1 channel activity were studied using a thallium-based fluorescent assay and patch-clamp electrophysiological recordings, both performed in HEK293 stably expressing the human Kv10.1 potassium channel. Results In thallium-sensitive fluorescent assays, we found that the small molecules loperamide and amitriptyline exert a potent inhibition on the activity of the oncogenic potassium channel Kv10.1. These results were confirmed by electrophysiological recordings, which showed that loperamide and amitriptyline decreased the amplitude of Kv10.1 currents in a dose-dependent manner. Both drugs could be promising tools for further studies. Conclusions Thallium-sensitive fluorescent assay represents a reliable methodological tool for the primary screening of different molecules with potential activity on Kv10.1 channels or other K+ channels.

Filiaciones:
Loza-Huerta, Arlet:
 Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico

Milo, Edgar:
 Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico

Picones, Arturo:
 Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico

Hernandez-Cruz, Arturo:
 Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico

 Univ Nacl Autonoma Mexico, Dept Neurociencia Cognit, Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico

Luis, Enoch:
 Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico

 Univ Nacl Autonoma Mexico, Catedras CONACYT Inst Fisiol Celular, Circuito Exterior S-N, Mexico City 04510, DF, Mexico
ISSN: 17341140





PHARMACOLOGICAL REPORTS
Editorial
Elsevier BV, SMETNA 12, 31-343 KRAKOW, POLAND, Polonia
Tipo de documento: Article
Volumen: 73 Número: 6
Páginas: 1744-1753
WOS Id: 000669198900001
ID de PubMed: 34213738